(INFU) Lyxor US$ 10Y Inflation - Ratings and Ratios
Inflation, Bonds, Derivatives, Futures, Indices
Description: INFU Lyxor US$ 10Y Inflation
The Lyxor US$10Y Inflation Expectations UCITS ETF - C-USD EUR (PA:INFU) is an exchange-traded fund that provides exposure to US 10-year inflation expectations. As an ETF, it allows investors to trade this specific market view with the flexibility of a stock.
To understand the funds performance, we can analyze its price movements. Although the current price is 115.79, its below its 200-day moving average of 120.64, indicating a downtrend. The Average True Range (ATR) of 0.27, or 0.24%, suggests relatively low volatility. Key Performance Indicators (KPIs) to monitor include the funds tracking error, which measures its deviation from the underlying index, and its expense ratio, which affects its net returns.
With Assets Under Management (AUM) of 207.17M EUR, the fund has a moderate size, suggesting sufficient liquidity for most investors. To further evaluate its attractiveness, we should consider its correlation with other assets in a portfolio, its historical returns during different market conditions, and its Sharpe ratio, which assesses risk-adjusted performance. These metrics will help determine if the ETF aligns with an investors strategy and risk tolerance.
Investors should also be aware of the underlying index methodology and how it reflects US 10-year inflation expectations. Understanding the index construction and rebalancing frequency is crucial for anticipating potential changes in the ETFs holdings and performance. Additionally, comparing the ETFs performance and characteristics with those of similar funds can help identify the most suitable investment.
Additional Sources for INFU ETF
INFU ETF Overview
Market Cap in USD | 242m |
Category | Other |
TER | 0.25% |
IPO / Inception | 2016-04-13 |
INFU ETF Ratings
Growth Rating | 47.2 |
Fundamental | - |
Dividend Rating | 0.0 |
Rel. Strength | -12.3 |
Analysts | - |
Fair Price Momentum | 111.90 EUR |
Fair Price DCF | - |
INFU Dividends
Currently no dividends paidINFU Growth Ratios
Growth Correlation 3m | -54.5% |
Growth Correlation 12m | 5.6% |
Growth Correlation 5y | 87.4% |
CAGR 5y | 7.92% |
CAGR/Max DD 5y | 0.63 |
Sharpe Ratio 12m | -0.22 |
Alpha | -6.08 |
Beta | 0.103 |
Volatility | 8.34% |
Current Volume | 0.1k |
Average Volume 20d | 0k |
Stop Loss | 112.6 (-3%) |
As of July 16, 2025, the stock is trading at EUR 116.08 with a total of 56 shares traded.
Over the past week, the price has changed by +1.25%, over one month by +1.15%, over three months by +0.25% and over the past year by -1.04%.
Partly, yes. Based on ValueRay´s Analyses, Lyxor US$ 10Y Inflation (PA:INFU) is currently (July 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 47.15 and therefor an somewhat technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of INFU is around 111.90 EUR . This means that INFU is currently overvalued and has a potential downside of -3.6%.
Lyxor US$ 10Y Inflation has no consensus analysts rating.
According to our own proprietary Forecast Model, INFU Lyxor US$ 10Y Inflation will be worth about 120.9 in July 2026. The stock is currently trading at 116.08. This means that the stock has a potential upside of +4.12%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 120.9 | 4.1% |